- cafead May 29, 2023 at 12:32: PM
via Lexicon Pharmaceuticals (Lexicon) has received approval from the US Food and Drug Administration (FDA) for its Inpefa drug to treat heart failure.
Inpefa is a once-daily oral tablet indicated as an inhibitor of sodium-glucose co-transporter type 2 (SGLT2) and type 1 (SGLT1).
It is intended to lower the risk of cardiovascular death, urgent heart failure visit, and hospitalisation for heart failure.
article source
Inpefa is a once-daily oral tablet indicated as an inhibitor of sodium-glucose co-transporter type 2 (SGLT2) and type 1 (SGLT1).
It is intended to lower the risk of cardiovascular death, urgent heart failure visit, and hospitalisation for heart failure.
article source